{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/itch-in-pregnancy/prescribing-information/chlorphenamine/","result":{"pageContext":{"chapter":{"id":"95ba7b87-a960-57fd-a754-512d887c1296","slug":"chlorphenamine","fullItemName":"Chlorphenamine","depth":2,"htmlHeader":"<!-- begin field 2875be47-4caf-42b6-b69c-ddd0a628019e --><h2>Chlorphenamine</h2><!-- end field 2875be47-4caf-42b6-b69c-ddd0a628019e -->","summary":"","htmlStringContent":"<!-- begin item afa46253-fa37-4187-9940-e59e09472207 --><!-- end item afa46253-fa37-4187-9940-e59e09472207 -->","topic":{"id":"830ea1e2-cb32-5c3f-9bff-b97f40f4fdca","topicId":"0ea3d4a3-2427-4849-bc55-80054c49c404","topicName":"Itch in pregnancy","slug":"itch-in-pregnancy","lastRevised":"Last revised in April 2020","chapters":[{"id":"cfb00c8c-6b8d-5313-9235-db3d54ef9fe2","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"eb121430-1a25-5f13-9fae-e0b66a6b9f12","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"cb1d8e5a-761d-5459-b261-5a39bace8e7f","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"43d69926-3fda-5446-98f6-e702b6f6a7bc","slug":"changes","fullItemName":"Changes"},{"id":"d38ab0ab-9d26-5e9c-8a65-c84f757478c4","slug":"update","fullItemName":"Update"}]},{"id":"51cdc19e-100c-53e7-b29f-5d685b193048","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"8902a748-b146-5b57-abe1-091451c77944","slug":"goals","fullItemName":"Goals"},{"id":"a059b067-209f-59db-907b-726070df2908","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"3e6e44dc-28c7-5241-93f5-7325020d69f0","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6dd5be7f-5719-51e5-9ba3-4bd276d58393","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ff4b1619-d0fa-5a30-b016-f752dd1a58ec","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a9d890cc-f5a8-50dc-a480-972af8996451","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"da0e2154-9689-5cce-bf1c-6a631089e0db","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"62eeef76-fe68-5156-8085-03cdcbda803d","slug":"definition","fullItemName":"Definition"},{"id":"0c1f2380-13c7-59b1-99eb-5a7b0bea6df1","slug":"causes-of-itch","fullItemName":"Causes of itch"},{"id":"03c01225-fd1c-59bf-8dc6-05e6ed9e7571","slug":"prevalence","fullItemName":"Prevalence"},{"id":"5c2186b4-396a-58cc-b5e6-89001f52feb2","slug":"complications","fullItemName":"Complications"},{"id":"6a1b05f7-a260-5843-8da6-4199a052e79c","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"c5cff2c3-a8d5-51b1-9c4f-e05a6c1e890e","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"7390b761-94e3-52ac-86d9-c4b8335b24da","slug":"causes-of-itch-without-rash","fullItemName":"Causes of itch without rash"},{"id":"318b78d3-8010-58d9-9a19-916fad7e9769","slug":"causes-of-itch-with-rash","fullItemName":"Causes of itch with rash"},{"id":"39a5a741-f8bd-57ac-bbdb-2afb0b87c766","slug":"itch-unrelated-to-pregnancy","fullItemName":"Itch unrelated to pregnancy"}]},{"id":"a6853d85-eed6-58d5-8861-02a8153e3a4b","fullItemName":"Management","slug":"management","subChapters":[{"id":"993d5c0f-c002-5409-8b0a-7185531987ec","slug":"itch-without-rash","fullItemName":"Scenario: Itch without rash"},{"id":"d71e492d-d64c-5494-84d9-05cd71b8bfe2","slug":"itch-with-rash","fullItemName":"Scenario: Itch with rash"}]},{"id":"e914c4d5-d732-56b3-9139-5073d0105c5d","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"694b14b1-caab-5453-99fd-f87ffe47434c","slug":"emollients","fullItemName":"Emollients"},{"id":"9b27ac31-e5d0-5667-89cc-8fa7da893cbf","slug":"corticosteroids","fullItemName":"Corticosteroids"},{"id":"95ba7b87-a960-57fd-a754-512d887c1296","slug":"chlorphenamine","fullItemName":"Chlorphenamine"},{"id":"895255b5-5d22-52f0-803f-9c0934c95f35","slug":"promethazine","fullItemName":"Promethazine"}]},{"id":"570034fe-13c6-513c-8ce3-7c1e20f7eb49","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"39893599-718c-523b-ace7-8b45f527372a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"c92e06b1-1592-5069-91ce-9207ee694663","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3934dfd9-4d45-5afc-911c-e59b298c6799","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"9f045912-2ce4-5a89-a031-2981e7057c12","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"0bf093ec-c04a-57d7-966f-9bfa8d0117bd","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"27b7fe79-30e3-5856-a8be-a7794359739c","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3d4b2031-ea07-5c95-9f4e-2d40e8b37e40","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"e914c4d5-d732-56b3-9139-5073d0105c5d","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"31682f15-8a98-5b08-a1d6-cab7e48e97a7","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 1d4b8799-4738-4f53-a936-603abb18db51 --><h3>Contraindications and cautions</h3><!-- end field 1d4b8799-4738-4f53-a936-603abb18db51 -->","summary":"","htmlStringContent":"<!-- begin item 63583019-4774-499c-a165-9fd4b4eb2976 --><!-- begin field a438d158-928c-4eb7-aded-cc68826e2687 --><ul><li>Chlorphenamine is <em>not </em>contraindicated in pregnancy (but is not specifically licensed for use in pregnancy). Use around the time of delivery may cause irritability, paradoxical excitability, and tremor in the neonate.</li></ul><p><strong>Chlorphenamine should be used with caution in people with:</strong></p><ul><li>Hepatic impairment — avoid sedating antihistamines in severe liver disease (obstetric cholestasis does not qualify as severe liver disease).</li><li>Renal impairment.</li><li>Severe hypertension or cardiovascular disease.</li><li>Raised intraocular pressure or glaucoma.</li><li>Pyloroduodenal obstruction.</li><li>Epilepsy — avoid antihistamines if possible, as they reduce the seizure threshold.</li><li>Asthma, bronchitis, or bronchiectasis.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">ABPI, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Joint Formulary Committee, 2020</a>]</p><!-- end field a438d158-928c-4eb7-aded-cc68826e2687 --><!-- end item 63583019-4774-499c-a165-9fd4b4eb2976 -->","subChapters":[]},{"id":"8f1d1dd1-93f1-5fa7-bd3f-fa983c4a8ee6","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 55dc489f-dad4-4489-aace-9a9ec61f05d8 --><h3>Adverse effects</h3><!-- end field 55dc489f-dad4-4489-aace-9a9ec61f05d8 -->","summary":"","htmlStringContent":"<!-- begin item 5beb680a-5f70-4c94-ad5e-bccd7b1ea53e --><!-- begin field 657c2ff6-bd33-4e66-9c6b-245f39d6efcb --><p><strong>Adverse effects of chlorphenamine include:</strong></p><ul><li>Neurological — dizziness, restlessness, tinnitus, psychomotor impairment, headaches, sedation that can persist for up to 12 hours (affected people should not drive or operate heavy machinery), muscle twitching.</li><li>Anticholinergic effects — blurred vision, dry mouth, and urinary retention.</li><li>Skin — urticaria, rash, exfoliative dermatitis, photosensitivity.</li><li>Gastrointestinal — nausea, vomiting, abdominal pain, diarrhoea, dyspepsia, anorexia, hepatitis.</li><li>Cardiovascular — palpitations, tachycardia, arrhythmias, hypotension.</li><li>Neuropsychiatric — depressed mood, excitation, irritability, nightmares, confusion.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">ABPI, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Joint Formulary Committee, 2020</a>]</p><!-- end field 657c2ff6-bd33-4e66-9c6b-245f39d6efcb --><!-- end item 5beb680a-5f70-4c94-ad5e-bccd7b1ea53e -->","subChapters":[]},{"id":"49c06da9-53f5-556d-ad42-03a7e2c70abf","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 3c43bf9d-8502-4bd8-8c4b-3a0a7d90e7ef --><h3>Drug interactions</h3><!-- end field 3c43bf9d-8502-4bd8-8c4b-3a0a7d90e7ef -->","summary":"","htmlStringContent":"<!-- begin item 8de3cce0-2d6d-4735-a500-45e73f0f8767 --><!-- begin field 697db263-30e9-4d31-8f1e-9aba2bf22336 --><ul><li><strong>Use of chlorphenamine is contraindicated where treatment with a monoamine oxidase inhibitor (MAOI) has occurred within the last 14 days </strong>— the anticholinergic properties of chlorphenamine are intensified by MAOIs.</li><li><strong>Combinations requiring caution include:</strong><ul><li>Hypnotics and anxiolytics — may cause an increase in sedative effects.</li><li>Phenytoin — chlorphenamine inhibits phenytoin metabolism and can lead to phenytoin toxicity.<ul><li>If symptoms of toxicity are present (confusion, blurred vision, nystagmus, ataxia, or drowsiness), monitor serum phenytoin levels and reduce the dose if necessary.</li></ul></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">ABPI, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Joint Formulary Committee, 2020</a>]</p><!-- end field 697db263-30e9-4d31-8f1e-9aba2bf22336 --><!-- end item 8de3cce0-2d6d-4735-a500-45e73f0f8767 -->","subChapters":[]},{"id":"4f623d99-392e-5625-b2ec-137de4bede6b","slug":"dosing-information","fullItemName":"Dosing information","depth":3,"htmlHeader":"<!-- begin field 315d37d0-f1d3-4539-b621-8522f833d35f --><h3>Dosing information</h3><!-- end field 315d37d0-f1d3-4539-b621-8522f833d35f -->","summary":"","htmlStringContent":"<!-- begin item 567817a5-0b3e-41f8-822c-6123c7690375 --><!-- begin field fb5e0c8f-58f9-4058-8e98-0b2b47599429 --><ul><li>Prescribe chlorphenamine 4 mg; to be taken at bedtime (note: as chlorphenamine is being used for its sedative effect, CKS advises the use of a single dose at night).<ul><li>People should be advised not to drive or operate heavy machinery if sedation is an ongoing adverse effect.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">ABPI, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Joint Formulary Committee, 2020</a>]</p><!-- end field fb5e0c8f-58f9-4058-8e98-0b2b47599429 --><!-- end item 567817a5-0b3e-41f8-822c-6123c7690375 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}